ProclaimRx introduces an AI-integrated marketing mix modeling solution, enabling biopharma commercial teams to transform static data into a dynamic operating model for investment optimization.
ProclaimRx announced the launch of a new marketing mix modeling product for biopharma companies, which is a positive company-specific development with no indicated public market impact.
ProclaimRx has unveiled a new AI-powered marketing mix modeling (MMM) platform designed specifically for the biopharmaceutical sector. The tool aims to provide commercial teams with transparent, on-demand insights to optimize investment strategies and improve operational decision-making.
The platform serves as an AI-driven marketing mix modeling tool that provides biopharma commercial teams with on-demand, transparent insights to optimize their investment strategies.